Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
PFM Health Sciences
AddedFeb 13, 2024
UpdatedJun 28, 2026
PFM Health Sciences

PFM Health Sciences

Operating

PFM Health Sciences: A San Francisco-based firm specializing in healthcare investment management.

Location
San Francisco, CA, US
Founded
2004
Firm
Compare
Portfolio
Employees
Website

PFM Health Sciences is a San Francisco-based investment firm specializing in healthcare, focusing on biopharma, medical technology, life sciences, and healthcare services. The firm typically invests in later-stage rounds, including Series B, C, D, and beyond, with notable involvement in Series C rounds. Their investment strategy supports both public and private companies, aiming to advance innovation within the healthcare sector.

Led by Founding Partner and CIO Brian Grossman, PFM Health Sciences boasts a portfolio of notable companies such as Collective Health, Caribou Biosciences, and Metagenomi. The firm emphasizes a deep commitment to fostering transformative healthcare innovations. PFM Health Sciences provides strategic support and leverages its extensive industry expertise to help portfolio companies navigate growth and achieve significant milestones.

PFM Health Sciences - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments13
Current Portfolio Count12
Total Portfolio Exits0

Top Investment Stages

Series C7 (53.8%)
Series B2 (15.4%)
Series D2 (15.4%)
Series A1 (7.7%)
Series F1 (7.7%)

Stage Mix

Series C 54%Series B 15%Series D 15%Series A 8%Series F 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Boundless Bio logo

Boundless Bio

Escient Pharmaceuticals logo

Escient Pharmaceuticals

Metagenomi logo

Metagenomi

Apella logo

Apella

Lark logo

Lark

Caresyntax logo

Caresyntax

NiKang Therapeutics logo

NiKang Therapeutics

Collective Health logo

Collective Health

Crossover Health logo

Crossover Health

Caribou Biosciences logo

Caribou Biosciences

Personal Genome Diagnostics logo

Personal Genome Diagnostics

Cytrellis Biosystems logo

Cytrellis Biosystems

PFM Health Sciences - Similar Investment Firms

Partner Fund Management logo

Partner Fund Management

Petrichor Healthcare Capital Management logo

Petrichor Healthcare Capital Management

petrichorcap.com

PBM Capital Group logo

PBM Capital Group

pbmcap.com

Health2047 Capital Partners logo

Health2047 Capital Partners

Patient Square Capital logo

Patient Square Capital

Nan Fung Life Sciences logo

Nan Fung Life Sciences

Pfizer Venture Investments logo

Pfizer Venture Investments

pfizer.com

Parkman Healthcare Partners logo

Parkman Healthcare Partners

parkmanhp.com

HealthTrend Capital logo

HealthTrend Capital

healthtrendcap.com

CB Health Ventures logo

CB Health Ventures

Population Health Partners logo

Population Health Partners

populationhp.com

PTV Healthcare Capital logo

PTV Healthcare Capital

Fairmount Funds Management logo

Fairmount Funds Management

fairmountfunds.com

Pacific Rim Ventures logo

Pacific Rim Ventures

Blue Ox Healthcare Partners logo

Blue Ox Healthcare Partners

blueoxhcp.com

PFM Health Sciences - Classification

Also Known As
  • PFM Health Sciences LP
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end